SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950123-99-007250
Filing Date
1999-08-06
Accepted
1999-08-06 00:00:00
Documents
1
Period of Report
1999-07-30

Document Format Files

Seq Description Document Type Size
1 NYMOX PHARMACEUTICAL CORPORATION 6-K 2020
  Complete submission text file 0000950123-99-007250.txt   3460
Mailing Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA, H9S 1B1 A8
Business Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA H9S 1B1 A8 5146363122
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 99679514
SIC: 2835 In Vitro & In Vivo Diagnostic Substances